Latest AMD Stories
CMS decision will provide patients access to VisionCare's AMD telescope in surgical facilities where 80% of ophthalmic surgeries are conducted SARATOGA, Calif., Nov.
Implanted Lens System is a Novel Solution for Dry AMD Symptoms CHICAGO, October 21, 2014 /PRNewswire/ -- London Eye Hospital Pharma, a London based medical device
Ophthotech/Novartis's Fovista Will Exceed $500 Million in 2023 Sales as a Treatment for the Wet Form of the Disease, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
SARATOGA, Calif., Oct. 13, 2014 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc.
-- Fourth indication for injection treatment that can stabilize and improve vision(1) -- mCNV a leading cause of visual impairment among those 20-50 years of age(9) Since
Indosoft, developer of Q-Suite call center software, announces the addition of support for Sangoma Lyra Answering Machine Detection. Fredericton, NB (PRWEB)
SAN DIEGO, Sept.
Fovista and Abicipar Pegol Will Need to be Priced Competitively to Current Agents to Garner Favorable Tier Placement, According to Findings from Decision Resources Group BURLINGTON, Mass.,
- A transitional zone between two communities containing the characteristic species of each.